# RNN 2nd Gen Model Medtronic, Inc. Electromedical equipment

Stock predictor AI models:
Subscribe >> Deal exit on
Dec. 14, 2020
Deal entry on
Dec. 14, 2020
4.21%Expected margin
73.33% successful of 60 deals
$ 119.86 Last close price
at 29-oct-2021


Model's trade recommendations No return for period yet

-0.76% Annual return

$108.32B Market Cap

β 0.94  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period
52wk return 7.05%
52wk Range
Sortino ratio -0.03
Sharpe ratio -0.02
Norm. RMSE 4.33%
Downside risk 10.82%
Volatility 0.00%
  • 1.84 (2.30%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Industry sector: Medical

Sector classification: Electromedical equipment

Deep Learning based analysis and prediction model for Medtronic, Inc. (MDT) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for MDT model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for MDT.

Model is being retrained on a regular basis.

Float 1351M
P/E 17.04
Shares Outstanding 1355M
% Held by Insiders 0.31%
% Held by Institutions 81.87%
EPS (last reported FY) $4.60
EPS (last reported Q) $1.17
EPS, estimated (last reported Q) $1.16
Total revenues $30 B
Net income $4 B